Jeff Lagasse
Healthcare organizations should enter into smart contracts with their eyes open and take steps to ensure the mitigation of risk.
Creative thinking will be needed to carve out the necessary critical care capacity to address the surge in COVID-19 patients.
Various hospital challenges are feeding off each other as three out of four hospitals treat patients with coronavirus symptoms, OIG report says.
Revenue is tanking, while expenses are going up, as organizations prepare for big surges in coronavirus cases.
Consumers will feel these increased costs through higher out-of-pocket expenses and premiums, especially if the federal response is lacking.
Cities that adopted early, broad isolation and prevention measures had lower disease and mortality rates during the Spanish flu era.
Forgoing these medications would increase health risks for millions of patients with hypertension and congestive heart failure.
With COVID-19 spreading, Trump has suggested that the increase in demand for supplies may not be due solely to the virus.
Some of the medications being used to treat COVID-19 are known to increase cardiac risk in some people.
The message is clear: Nurses and physicians should treat asymptomatic patients as carefully as symptomatic patients.